These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38375481)

  • 21. Functional Brain Network Alterations in Patients With Systemic Lupus Erythematosus With Different Cognitive Function States: A Graph Theory Analysis Study.
    Li X; Xia J; Hu J; Chen Q; Li Y; Yin M; Zou H; Zhou W; Zhang P
    J Comput Assist Tomogr; 2024 Mar-Apr 01; 48(2):283-291. PubMed ID: 37757812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age of onset correlates with clinical characteristics and prognostic outcomes in neuromyelitis optica spectrum disorder.
    Hu Y; Sun Q; Yi F; Yao L; Tian Y; Tang H; Luo M; Xie N; Wang Z; Liao X; Zhou L; Xu H; Zhou Y
    Front Immunol; 2022; 13():1056944. PubMed ID: 36569880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: anxiety, disability, fatigue and depression.
    Shi Z; Chen H; Lian Z; Liu J; Feng H; Zhou H
    J Neuroimmunol; 2016 Apr; 293():54-58. PubMed ID: 27049562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between cerebral cortex changes and clinical features in patients with neuromyelitis optica spectrum disorder with normal-appearing brain tissue: a case-control study.
    Huang C; Li Y; Chen Y; Liao X; Zhang H; Wang Z; Liu J; Lu W
    Neural Regen Res; 2023 Nov; 18(11):2520-2525. PubMed ID: 37282485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics of very late-onset neuromyelitis optica spectrum disorder.
    Cai LJ; Zhang Q; Zhang Y; Chen HX; Shi ZY; Du Q; Zhou HY
    Mult Scler Relat Disord; 2020 Nov; 46():102515. PubMed ID: 33032051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.
    Pasquier B; Borisow N; Rasche L; Bellmann-Strobl J; Ruprecht K; Niendorf T; Derfuss TJ; Wuerfel J; Paul F; Sinnecker T
    Neurol Neuroimmunol Neuroinflamm; 2019 May; 6(3):e541. PubMed ID: 30882018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing the degree of disability in patients with neuromyelitis optica spectrum disorders.
    Shi L; Li D; Zhang Y; Wang J; Fu J; Liu X; Wang P
    Eur J Med Res; 2023 Oct; 28(1):426. PubMed ID: 37821922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered functional connectivity associated with cognitive impairment in neuromyelitis optica spectrum disorder.
    Yang Y; Rui Q; Wu X; Chen X; Han S; Yang Y; Wang X; Wu P; Dai H; Xue Q; Li Y
    Mult Scler Relat Disord; 2022 Dec; 68():104113. PubMed ID: 35987110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disrupted topological organization of functional brain networks is associated with cognitive impairment in hypertension patients: a resting-state fMRI study.
    Liao D; Zhang ZQ; Guo ZP; Tang LR; Yang MH; Wang RP; Liu XF; Liu CH
    Neuroradiology; 2023 Feb; 65(2):323-336. PubMed ID: 36219250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural disconnection is associated with disability in the neuromyelitis optica spectrum disorder.
    Kim M; Choi KS; Hyun RC; Hwang I; Kwon YN; Sung JJ; Kim SM; Kim JH
    Brain Imaging Behav; 2023 Dec; 17(6):664-673. PubMed ID: 37676409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum antinuclear antibodies associate with severe disease activity in neuromyelitis optica spectrum disorder.
    Wang R; Sun DR; Du Q; Zhang Y; Chen HX; Wang XF; Kong LY; Luo WQ; Shi ZY; Zhou HY
    J Neuroimmunol; 2023 Sep; 382():578151. PubMed ID: 37453208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered large-scale individual-based morphological brain network in spinocerebellar ataxia type 3.
    Su S; Sha R; Qiu H; Chu J; Lin L; Qian L; Hu M; Wu C; Cheung GL; Yang Z; Chen Y; Zhao J
    CNS Neurosci Ther; 2023 Dec; 29(12):4102-4112. PubMed ID: 37392035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined platelet-to-lymphocyte ratio and blood-brain barrier biomarkers as indicators of disability in acute neuromyelitis optica spectrum disorder.
    Yan H; Wang Y; Li Y; Shen X; Ma L; Wang M; Du J; Chen W; Xi X; Li B
    Neurol Sci; 2024 Feb; 45(2):709-718. PubMed ID: 37676374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain structural and functional connectivity alterations are associated with fatigue in neuromyelitis optica spectrum disorder.
    Zhang Y; Chen HX; Shi ZY; Du Q; Wang JC; Wang XF; Qiu YH; Lang YL; Kong LY; Cai LJ; Lin X; Mou ZC; Luo WQ; Li SJ; Zhou HY
    BMC Neurol; 2022 Jun; 22(1):235. PubMed ID: 35761294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders.
    Wang X; Yi H; Liu J; Li M; Mao ZF; Xu L; Peng FH
    J Neurol Sci; 2016 Jul; 366():3-7. PubMed ID: 27288767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T1 hypointense brain lesions in NMOSD and its relevance with disability: a single institution cross-sectional study.
    Ghazanfari Hashemi M; Talebi V; Abbasi Kasbi N; Abbasi M; Asgari N; Sahraian MA
    BMC Neurol; 2024 Feb; 24(1):62. PubMed ID: 38347476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of individual-based morphological brain network alterations in children with attention-deficit/hyperactivity disorder: a multi-method investigation.
    Su S; Chen Y; Qian L; Dai Y; Yan Z; Lin L; Zhang H; Liu M; Zhao J; Yang Z
    Eur Child Adolesc Psychiatry; 2023 Nov; 32(11):2281-2289. PubMed ID: 36056264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations among disability, anti-AQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD.
    Hsu JL; Liao MF; Chang KH; Cheng MY; Ro LS
    BMC Neurol; 2021 Apr; 21(1):153. PubMed ID: 33836682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicentric clinical and epidemiological comparison of neuromyelitis optica spectrum disorder with multiple sclerosis from India.
    Gupta S; Rehani V; Acharya R; Purohit P; Anadure R; Ahmad F; Soni R; Gupta A; Hiremath R
    Mult Scler Relat Disord; 2021 Jan; 47():102616. PubMed ID: 33166808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.